October 01, 2016 2:28 PM ET

Healthcare Providers and Services

Company Overview of Aspen Global Incorporated

Company Overview

Aspen Global Incorporated operates as the holding company for the Aspen Group’s international businesses that manages and maintains the intellectual property rights, and regulatory and commercialization strategies of a portfolio of specialist and branded products. The company also performs procurement, distribution, and supply related operations. Its product portfolio comprises products for various therapeutic categories, such as anti-infective, cardiovascular and central nervous systems, hematology/oncology, hypothyroidism, immune system, metabolic diseases, and nonsteroidal anti-inflamatory drugs. The company was founded in 2008 and is based in Grand Baie, Mauritius. It has businesses in S...

301 GBS Plaza

cnr La Salette and Royal Roads

Grand Baie,  

Mauritius

Founded in 2008

Phone:

230 269 1111

Fax:

230 269 1112

Key Executives for Aspen Global Incorporated

Chief Executive Officer
Compensation as of Fiscal Year 2016.

Aspen Global Incorporated Key Developments

AstraZeneca PLC Completes Commercialization Agreement with Aspen Global Incorporated for Anaesthetics Portfolio

AstraZeneca PLC announced that it has completed the commercialization agreement with Aspen Global Incorporated (AGI), part of the Aspen Group, for rights to its global anaesthetics portfolio outside the US. The agreement covers seven established medicines - Diprivan (general anaesthesia), EMLA (topical anaesthetic) and five local anaesthetics (Xylocaine/Xylocard/Xyloproct, Marcaine, Naropin, Carbocaine and Citanest).

Astrazeneca Enters into Commercialization Agreement with Aspen Global Incorporated for Rights to its Global Anaesthetics Portfolio Outside the US

AstraZeneca announced it has entered into a commercialization agreement with Aspen Global Incorporated (AGI), part of the Aspen Group, for rights to its global anaesthetics portfolio outside the US. The agreement covers seven established medicines - Diprivan (general anaesthesia), EMLA (topical anaesthetic) and five local anaesthetics (Xylocaine/Xylocard/Xyloproct, Marcaine, Naropin, Carbocaine and Citanest). Under the terms of the agreement, AGI will acquire the commercialization rights, outside the US, to AstraZeneca's portfolio of anaesthetic medicines for an upfront consideration of $520 million. Additionally, AGI will pay AstraZeneca up to $250 million in a Product Sales-related payment, as well as double-digit percentage trademark royalties on Product Sales. AstraZeneca will manufacture and supply the products on a cost plus basis to AGI for an initial period of 10 years. Upon completion, Aspen will assume responsibility for all activities relating to the sale of the portfolio in all relevant markets.

Aspen Global Incorporated to Launch the Finished Dose Form Product Indicated for the Treatment of Certain Female Cancers and Hormonal Imbalances

Aspen Global Incorporated had acquired the intellectual property and the approved Abbreviated New Drug Application in the United States in respect of the finished dose form of Hydroxyprogesterone Caproate. Aspen announced that AGI expects to launch the finished dose form product, indicated for the treatment of certain female cancers and hormonal imbalances, in the United States during its current financial year which ends on 30 June 2016. Aspen is in advanced negotiations with a United States pharmaceutical company with proven capabilities in this category to distribute the HPC finished dose form. Aspen currently manufactures the active pharmaceutical ingredient for HPC and is a substantial supplier of HPC API to the United States. Aspen's launch of HPC injection is a realisation of Aspen's stated intent to develop commercial opportunities in the United States which are aligned to the intellectual property available within the Group.

Similar Private Companies By Industry

Company Name Region
British American Hospitals Entreprises Ltd. Middle East/Africa
Integrated Health and Healthcare Services Middle East/Africa
Med Point Ltd Middle East/Africa
Aspen Global Incorporated Middle East/Africa
HCG (Mauritius) Pvt. Ltd. Middle East/Africa

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
September 12, 2016
GlaxoSmithKline plc, Anaesthetics Portfolio
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Aspen Global Incorporated, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.